MeiraGTx Holdings (MGTX) Non-Current Debt (2021 - 2025)
MeiraGTx Holdings (MGTX) posted Non-Current Debt of $49.7 million for Q4 2025, down 32.65% on a QoQ basis from $73.8 million in Q2 2025, and down 32.14% year-over-year from $73.2 million in Q4 2024.
MeiraGTx Holdings (MGTX) Non-Current Debt (2021 - 2025) Analysis & Trends
MeiraGTx Holdings' Non-Current Debt history runs 5 years deep, the most recent figure standing at $49.7 million for Q4 2025.
- Quarterly Non-Current Debt fell 32.14% year-over-year to $49.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $49.7 million (down 32.14% YoY) and the FY2025 annual result came in at $49.7 million, down 32.14% from the prior year.
- Non-Current Debt was $49.7 million for Q4 2025 at MeiraGTx Holdings, down from $73.8 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $73.8 million in Q2 2025 and bottomed at $208000.0 in Q1 2023.
- A 5-year average of $48.6 million and a median of $71.7 million in 2023 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2022 — Non-Current Debt sank 72.51% — and 2024, when it surged 34703.37%.
- MeiraGTx Holdings' Non-Current Debt stood at $953000.0 in 2021, then sank by 72.51% to $262000.0 in 2022, then soared by 27426.34% to $72.1 million in 2023, then rose by 1.53% to $73.2 million in 2024, then slumped by 32.14% to $49.7 million in 2025.
- Business Quant data shows MGTX's Non-Current Debt at $49.7 million in Q4 2025, $73.8 million in Q2 2025, and $73.5 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | MeiraGTx Holdings | 973.21 Mn | 907.27 Mn | - | 49.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 49.69 Mn |
| Jun 30, 2025 | 73.77 Mn |
| Mar 31, 2025 | 73.50 Mn |
| Dec 31, 2024 | 73.22 Mn |
| Sep 30, 2024 | 72.94 Mn |
| Jun 30, 2024 | 72.67 Mn |
| Mar 31, 2024 | 72.39 Mn |
| Dec 31, 2023 | 72.12 Mn |
| Sep 30, 2023 | 71.84 Mn |
| Jun 30, 2023 | 71.57 Mn |
| Mar 31, 2023 | 208,000.00 |
| Dec 31, 2022 | 262,000.00 |
| Sep 30, 2022 | 70.85 Mn |
| Jun 30, 2022 | 304,000.00 |
| Mar 31, 2022 | 556,000.00 |
| Dec 31, 2021 | 953,000.00 |